C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
11/2002
11/07/2002	WO2002087589A1 Medicine for inhibiting drug elimination pump
11/07/2002	WO2002087587A2 4-aminosulfonylquinazolines and -quinolines as tyrosine kinase inhibitors
11/07/2002	WO2002087580A1 Abc expression promoters
11/07/2002	WO2002087513A2 Fused heterocyclic inhibitors of phosphodiesterase (pde) 7
11/07/2002	WO2002087338A1 Liquid formulations for dermal application in treatment of parasitic insects in animals
11/07/2002	US20020165415 Synthesis of epothilones
11/07/2002	US20020165412 N-(aryl)-2-arylethenesulfonamides and therapeutic uses thereof
11/07/2002	US20020165259 Such as ethyl-3-((E)-2-acetamido-thiazol-5-yl)-acrylate for treatment of cancer, proliferative diseases, inflammation, and arthritis
11/07/2002	US20020165257 For patients exhibiting resistance to oncology and chemotherapy with taxanes; antiproliferative agents
11/07/2002	US20020165253 Such as N-(4-chlorobenzyl)-8-(4-hydroxybut-1-ynyl)-1-methyl-6-(morpholin-4-ylmethyl)-4-oxo-1,4-dihydroquinoline-3-carboxamide for treatment against herpes viruse; enzyme inhibitors
11/07/2002	US20020165252 Such as methyl-2-cyclopentyl-4-(4-fluorophenyl)-5-oxo-7,7-dimethyl-1,4,5,6,7,8 -hexahydroquinoline-3-carboxylate for treatment of arteriosclerosis and dyslipidaemias; condensation
11/07/2002	US20020165241 Such as 4-((methyl-pyrimidin-2-ylamino)-methyl)-piperidine-1-carboxylic acid benzyl ester; useful for pain relief; treating migraine, depression, anxiety, schizophrenia, Parkinson's disease, and stroke; N-methyl-D-aspartate (NMDA)
11/07/2002	US20020165223 Eating disorders; anticholesterol agents; hypotensive agents; sleep disorders
11/07/2002	US20020165219 Novel heterocycles useful in the treatment of benign prostatic hyperplasia
11/07/2002	US20020165218 Mixture of kinase inhibitor and anticancer agents
11/07/2002	US20020165203 Enzyme inhibitors; antiinflammatory agents; rheumatic diseases; antidiabetic agents
11/07/2002	CA2665516A1 Drug efflux pump inhibitor
11/07/2002	CA2445697A1 Drug efflux pump inhibitor
11/07/2002	CA2445568A1 Triazole-derived kinase inhibitors and uses thereof
11/07/2002	CA2445357A1 Pyrazole derived kinase inhibitors
11/07/2002	CA2445348A1 Novel benzylpiperidine compound
11/07/2002	CA2444499A1 Triazole compounds useful in treating diseases associated with unwanted cytokine activity
11/07/2002	CA2444436A1 Dual inhibitors of pde 7 and pde 4
11/07/2002	CA2443835A1 Fused heterocyclic inhibitors of phosphodiesterase (pde) 7
11/07/2002	CA2439943A1 Benzimidazoles that are useful in treating sexual dysfunction
11/06/2002	EP1255112A2 Treatment of T-cell mediated diseases
11/06/2002	EP1254904A1 Novel piperidine compounds and drugs containing the same
11/06/2002	EP1254897A1 Tricyclic compounds
11/06/2002	EP1254895A1 Nitrogenous cyclic compounds and pharmaceutical compositions containing the same
11/06/2002	EP1254667A1 Drug comprising combination
11/06/2002	EP1254136A1 FACTOR Xa INHIBITORS WITH ARYL-AMIDINES AND DERIVATIVES, AND PRODRUGS THEREOF
11/06/2002	EP1254135A2 Aminoheterocyclylamides as pesticides and antiparasitic agents
11/06/2002	EP1254133A2 Indol-3-yl derivatives
11/06/2002	EP1254123A1 2-benzothiazolyl urea derivatives and their use as protein kinase inhibitors
11/06/2002	EP1254119A1 Pyrimidine derivatives as selective inhibitors of cox-2
11/06/2002	EP1254115A2 Cannabinoid receptor modulators, their processes of preparation, and use of cannabinoid receptor modulators for treating respiratory and non-respiratory diseases
11/06/2002	EP1254113A1 N-substituted 2-cyanopyroles and -pyrrolines which are inhibitors of the enzyme dpp-iv
11/06/2002	EP1253925A1 Tetrahydropyrimidone inhibitors of fatty acid binding protein and method
11/06/2002	EP0940401B1 2-carbonylthiazole derivatives and use of the same
11/06/2002	EP0920421B1 Isoxazoline derivatives useful as antimicrobials
11/06/2002	EP0901488B1 2,4-diaminopyrimidine derivatives
11/06/2002	EP0898566B1 Substituted benzylamines and their use for the treatment of depression
11/06/2002	EP0871619B1 Phenyl thiazole derivatives with anti herpes virus properties
11/06/2002	EP0781280B1 Derivatives of benzopyran and of benzothiopyran, their preparation and their use as agonists of dopaminergic receptors
11/06/2002	CN1378546A Antibiotic sultam and sultone drived oxazolidiones
11/06/2002	CN1378543A Substituted pyridazines and fused pyridazines with angiogenesis inhibiting activity
11/06/2002	CN1378540A New piperazine and piperidine compounds
11/06/2002	CN1378539A Thiocarbamic acid derivatives
11/06/2002	CN1378537A 嘧啶衍生物 Pyrimidine derivatives
11/06/2002	CN1378534A Substituted polycyclic aryl and heteroaryl pyridones useful for selective inhibition of coagulation cascade
11/06/2002	CN1378533A Phenoxypropylamine compounds
11/06/2002	CN1378446A Method of inhibiting amyloid protein aggregation and imaging amyloid deposits
11/06/2002	CN1377880A Compound for curing vascular complication, its preparing method and treating use
11/05/2002	US6476226 Isoxazoline fibrinogen receptor antagonists
11/05/2002	US6476059 Use of polycyclic 2-aminothiazole systems for the treatment of obesity
11/05/2002	US6476055 5,5-disubstituted thiazolidine derivative pesticides
11/05/2002	US6476051 For therapy of psychosis, acute mania, mild anxiety states, or depression in combination with psychotic episodes
11/05/2002	US6476040 Processes and intermediates for preparing anti-cancer compounds
11/05/2002	US6476026 Compounds and compositions as protease inhibitors
10/2002
10/31/2002	WO2002085906A2 Phthalazinones derivatives useful as pde4/7 inhibitors
10/31/2002	WO2002085899A1 Heterocyclyldicarbamides as caspase inhibitors
10/31/2002	WO2002085891A1 2,6-substituted chroman derivatives useful as beta-3 adrenoreceptor agonists
10/31/2002	WO2002085885A1 Piperazino-derivatives and their use as pde4 inhibitor
10/31/2002	WO2002085870A1 Novel azoles having an insecticidal action
10/31/2002	WO2002085869A1 Arylsulfonamides as antiviral agents
10/31/2002	WO2002085866A1 Novel compounds
10/31/2002	WO2002085855A1 2-iminopyrrolidine derivatives
10/31/2002	WO2002085851A1 Pyrrole derivative
10/31/2002	WO2002085850A1 Cyclic amidine derivative
10/31/2002	WO2002085291A2 Nociceptin analogs
10/31/2002	WO2002051356A3 Inhalable aztreonam for treatment and prevention of pulmonary bacterial infections
10/31/2002	WO2002040474A3 Heterocyclylalkyl piperidine derivatives and their use as antimicrobial agents
10/31/2002	WO2002022611A3 Caspase inhibitors and uses thereof
10/31/2002	WO2000062766A3 Uses of ppar-gamma agonists in neutrophil-induced diseases
10/31/2002	US20020161237 (Z)-2-((2-bromo-4-(((3-hydroxybenzyl)amino)carbonyl)benzoyl) -amino)pent-2-enoic acid, for example; useful for treating psoriasis
10/31/2002	US20020161224 Diaryl ethers and processes for their preparation and herbicidal and desiccant compositions containing them
10/31/2002	US20020161024 Administering 2-(piperidin-2,6-dion-3-yl),4-amino-isoindolin-1-one to treat an eye condition
10/31/2002	US20020161019 For treatment of depression, anxiety, feeding disorders, headache, drug addiction, inflammatory disorders
10/31/2002	US20020161005 Nitrogen heterocycle compounds
10/31/2002	US20020161004 Antiinflammation agents
10/31/2002	US20020160992 Reversing advanced glycosylation cross-links using heterocyclic-substituted thiazolium salts
10/31/2002	US20020160983 Substituted benzopyranones as telomerase inhibitors
10/31/2002	US20020160932 Enzyme complex; treatment and prophylaxis of herpes infections; sulfonamide compounds of given formula
10/31/2002	CA2445236A1 Piperazino-derivatives and their use as pde4 inhibitor
10/31/2002	CA2445233A1 Phthalazinones derivatives useful as pde4/7 inhibitors
10/31/2002	CA2444592A1 Novel azoles having an insecticidal action
10/31/2002	CA2444381A1 Novel compounds
10/31/2002	CA2443600A1 Heterocyclyldicarbamides as caspase inhibitors
10/30/2002	EP1253142A1 Compounds exhibiting thrombopoietin receptor agonism
10/30/2002	EP1252159A1 Method for producing heterocyclic compounds
10/30/2002	EP1252158A1 Nicotinamide benzofused-heterocyclyl derivatives useful as selective inhibitors of pde4 isozymes
10/30/2002	EP1252157A1 Pyrimidine carboxamides useful as inhibitors of pde4 isozymes
10/30/2002	EP1252156A1 Blockade of voltage dependent sodium channels
10/30/2002	EP1252150A1 Novel heterocyclic derivatives, preparation method and pharmaceutical compositions containing same
10/30/2002	EP1252140A1 Pyrrolecarboxamides and pyrrolethioamides as fungicides
10/30/2002	EP1252139A1 Trifluoromethylpyrrole carboxamides and trifluoromethylpyrrolethioamides as fungicides
10/30/2002	EP1251848A1 Gyrase inhibitors and uses thereof
10/30/2002	EP0991410B1 Gastrokinetic bicyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivatives
10/30/2002	EP0852225B1 Fibrinogen receptor antagonists and medicinal preparations containing the same as the active ingredient
10/30/2002	EP0793660B1 2-substituted 1,2,5-thiadiazolidin-3-one 1,1-dioxides and compositions and method of use thereof

1 ... 412 413 414 415 416 417 418 419 420 421 422 423 424 425 426 427 428 429 430 431 432 ... 628